Impact November 2018 Volume 27 Supplement 1 Factor 27 4.151 S1 Volume 27 Issue S1 Volume Pages S1–S125 Pages HEATED TOBACCO PRODUCTS FROM T H E TOBACCO CONTROL TOBACCO HEALTH EFFECTS T O T H E POLITICS November 2018 Editor Ruth E. Malone (USA) Tobacco Control aims to study the nature and consequences of E: [email protected] Deputy Editors tobacco use worldwide; tobacco’s effects on population health, the Joanna Cohen (Canada) economy, the environment and society; efforts to prevent and control Senior Editors Joaquin Barnoya (Guatemala) the global tobacco epidemic through population level education and Coral Gartner (Australia) Lisa Henriksen (USA) policy changes; the ethical dimensions of tobacco control policies; and Sarah Hill (UK) Richard O’Connor (USA) the activities of the tobacco industry and its allies Editor Emeritus Simon Chapman (Australia) Associate Editors Editorial Advisory Deputy Editor Emeritus Addiction and pharmacology Board Contact Details Andrew Hyland (USA) Dorothy Hatsukami (USA) Chair News Analysis Editor Kenneth E. Warner (USA) Economics of Tobacco Control Editorial Office Marita Hefler (Australia) Frank Chaloupka (USA) Tobacco Control, BMJ Journals, BMA House Tavistock [email protected] Vice Chair Judith Mackay (Hong Kong) Square London, WC1H 9JR, UK Deputy News Editor Harm Reduction OA Ayo-Yusuf (South Africa) T: +44 (0)20 7383 6457 Stan Shatenstein (Canada) Lynn Kozlowski (USA) E: [email protected] Stella Aguinaga Bialous Consulting Editors for Methods/ Twitter: TC_BMJ Historical Perspectives on (USA/Brazil) Statistics Tobacco Control Policy Sophia Chan (Hong Kong) Christopher Keith Haddock (USA) Allan M. Brandt (USA) Production Editor David Hammond (Canada) Gregory N. Connolly (USA) Aradhana Mistry Karen Messer (USA) Human Rights and Tobacco Mike Cummings (USA) E: [email protected] Todd Rogers (USA) Control Advocacy Pascal Diethelm (Switzerland) Nina C Schleicher (USA) Stephen Marks (USA) Esteve Fernández (Spain) Customer support Mohammad Siahpush (USA) Stanton Glantz (USA) For general queries and support with existing and new Legislation and Regulation subscriptions: Regional editors Gary Giovino (USA) Europe: Anna Gilmore (UK) Jonathan Liberman (Australia) W: support.bmj.com Margaretha Haglund (Sweden) Africa: Yussuf Saloojee Litigation T: +44 (0)20 7111 1105 Luk Joossens (Belgium) (South Africa) Richard Daynard (USA) E: [email protected] North America: Roberta Ferrence Tom Novotny (USA) (Canada) Mass Media in Tobacco Control John P. Pierce (USA) Self-archiving and permissions Australasia: Sarah Durkin (AU) Lois Biener (USA) Tibor Szilagyi (Hungary) W: bmj.com/company/products-services/ Latin America and the Caribbean: Patterns and Predictors of Prakit Vathesatogkit (Thailand) rights-and-licensing/ E: [email protected] Vera Luiza da Costa e Silva (Brazil) Tobacco Use Melanie Wakefield (AU) South Asia: Prakash Gupta (India) Ron Borland (Australia) Asia-Pacific: Tai Hing Lam Corné van Walbeek (South Africa) Advertising Politics of Tobacco Control (Hong Kong) Representing: W: bmj.com/company/for-advertisers-and-sponsor/ Middle East: Elif Dagli (Turkey) Jeff Collin (UK) International Network of Women Display Advertising ROW Assistant Editor, Web & New Media Product Design David Ashley (USA) Against Tobacco Sophie Fitzsimmons Becky Freeman (Australia) Deborah McLellan (USA) T: +44 (0)20 3655 5612 Founding Editor Product Marketing and Promotion E: [email protected] Ron Davis (USA) Timothy Dewhirst (Canada) Framework Convention Alliance Laurent Huber (Switzerland) Online Advertising ROW Impact Factor: 4.151 Secondhand Smoke Marc Clifford Alistair Woodward (New Zealand) Guidelines for Authors and T: +44 (0)20 3655 5610 Reviewers Tobacco Industry Activities E: [email protected] Full instructions are available online at Elizabeth Smith (USA) http://tobaccocontrol.bmj.com/pages/ Display & Online Advertising Americas authors. Articles must be submitted Tobacco Use Prevention American Medical Communications (AMC) electronically http://authors.bmj.com/ Amanda Amos (UK) T: +1 973 214 4374 submitting-your-paper. Authors retain Smoking Cessation Policies E: [email protected] copyright but are required to grant Tobacco Shu-Hong Zhu (USA) Control an exclusive licence to publish Reprints (http://authors.bmj.com/ submitting-your- paper/copyright-and-authors-rights/). Author Reprints Subscription Information BMJ Reprints Team E: [email protected] Disclaimer: Tobacco Control is published Tobacco Control is published bimonthly; subscribers have access by BMJ Publishing Group Ltd, a wholly to all supplements Commercial Reprints ROW owned subsidiary of the British Medical Nadia Gurney-Randall Association. The publisher grants editorial Institutional Rates Personal Rates 2018 M: +44 (0)7866 262 344 freedom to the Editor of Tobacco Control. E: [email protected] Tobacco Control follows guidelines on 2018 Print (includes online access at editorial independence produced by the Commercial Reprints Americas Print no additional cost) World Association of Medical Editors and £255 Ray Thibodeau the code on good publication practice of £556 T: +1 267 895 1758 the Committee on Publication Ethics. M: +1 215 933 8484 Online Online only Tobacco Control is intended for medical £138 E: [email protected] professionals and is provided without Site licences are priced on FTE warranty, express or implied. Statements basis and allow access by the ISSN 0964-4563 (print); For all other Tobacco Control journal contacts in the Journal are the responsibility of their whole institution. 1468-3318 (online) http://tobaccocontrol.bmj.com/contact-us authors and advertisers and not authors’ institutions, the BMJ Publishing Group or Personal print or online only and the BMA unless otherwise specified or institutional print subscriptions may Copyright: © 2018 BMJ Publishing Group. All rights reserved; no part of determined by law. Acceptance of be purchased online at http:// this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, advertising does not imply endorsement. journals.bmj.com/content/subscribers? photocopying, recording or otherwise without prior permission To the fullest extent permitted by law, tobaccocontrol (payment by Visa/ Tobacco Control is published by BMJ Publishing Group Ltd, typeset by the BMJ Publishing Group shall not be liable Mastercard only). Exeter Premedia Services Private Ltd, Chennai, India, and printed in the UK on acid-free paper. for any loss, injury or damage Residents of some EC countries must pay VAT; for details, call us or visit resulting from the use of Tobacco Control http://journals.bmj.com/content/subscribers?tobaccocontrol Tobacco Control (ISSN 0964-4563) is published bi-monthly by BMJ or any information in it whether based on Publishing Group and distributed in the USA by Air Business Ltd. contract, tort or otherwise. Readers are For more information on subscription rates or to subscribe online please Periodicals postage paid at Jamaica NY 11431. POSTMASTER: send advised to verify any information they visit https://tobaccocontrol.bmj.com/pages/subscribe/ address changes to Tobacco Control, Air Business Ltd, c/o Worldnet Shipping Inc., 156-15, 146th Avenue, 2nd Floor, Jamaica, NY 11434, USA. choose to rely on. Commentary Heated tobacco products: the example of IQOS Stanton A Glantz ► Additional material is Heated tobacco products (HTP) represent the latest papers that present analyses of PMI’s application by published online only. To view in a long line of products tobacco companies have researchers independent of the tobacco industry and please visit the journal online 12 papers that provide independent assessments of (http:// dx. doi. org/ 10. 1136/ developed and marketed as less dangerous than tobaccocontrol- 2018- 054601). conventional cigarettes, beginning with so-called HTP effects, including their political and policy ‘safer cigarettes’ in the 1960s.1 2 HTP (figure 1) implications. Together, these papers provide insights Correspondence to heat tobacco to generate an inhaled nicotine aerosol into IQOS (and, in broad terms, other HTP) and Professor Stanton A Glantz, and are marketed using messages that explicitly or support the January 2018 vote by the FDA Tobacco Department of Medicine, Center 3–8 for Tobacco Control Research implicitly claim they are safer than cigarettes. Product Scientific Advisory Committee that PMI’s and Education, Cardiovascular In 2018, HTP were available in many countries application did not demonstrate it reduced risk Research Institute, Philip R. (table 1). In the USA, before marketing new tobacco claims for IQOS24 (online supplementary table S1). Lee Institute for Health Policy products, the Family Smoking Prevention and These papers also put HTP in the overall context of Studies, Helen Diller Family 9 the tobacco companies’ plans to maintain and grow Comprehensive Cancer Center, Tobacco Control Act (FSPTCA) requires premarket University of California, San review by the Food and Drug Administration (FDA) their markets in the future and outline regulatory Francisco, San Francisco, CA to demonstrate that marketing them would be responses. 94143-1390, USA; ‘appropriate for the protection of the public health’ glantz@ medicine. ucsf. edu (FSPTCA sections 910 and 905(j)). Additionally, HEALTH EFFECTS to market any new tobacco product in the USA The fundamental justification for introducing HTP with claims of reduced risk or reduced exposure